Sign Up Today and Learn More About KAHR medical Stock
Invest in or calculate the value of your shares in KAHR medical or other pre-IPO companies through EquityZen's platform.
KAHR medical Stock
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
About KAHR medical Stock
Founded
2005
Industries
Software, Artificial Intelligence, Data and Analytics
KAHR medical Press Mentions
Stay in the know about the latest news on KAHR medical
SIRPalpha-41BBL FUSION PROTEIN AND METHODS OF USE THEREOF
patents • Feb 01, 2026
COMBINED TREATMENT WITH A SIRPalpha-4-1BBL FUSION PROTEIN FOR CANCER
patents • Feb 01, 2026
SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
patents • Feb 01, 2026
KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
prnewswire • Jan 09, 2026
Lilrb polypeptides and uses thereof
patents • May 04, 2025
KAHR medical Management
Leadership team at KAHR medical
CEO
Yaron Pereg
Member of the Board of Directors
Carl-Johan Spak
Join now and verify your accreditation status to gain access to:
- KAHR medical Current Valuation
- KAHR medical Stock Price
- KAHR medical Management
- Available deals in KAHR medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- KAHR medical Cap Table and Funding History by Share Class and Liquidity Preferences
- KAHR medical Revenue and Financials
- KAHR medical Highlights
- KAHR medical Business Model
- KAHR medical Risk Factors
- KAHR medical Research Report from SACRA Research
Trading KAHR medical Stock
How to invest in KAHR medical stock?
Accredited investors can buy pre-IPO stock in companies like KAHR medical through EquityZen funds. These investments are made available by existing KAHR medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell KAHR medical stock?
Shareholders can sell their KAHR medical stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."